7U4-18534-57998
3 vaccinations
9 coded responses
27 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 984 / WA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
-
2021-03-25
Survey response — day 7, dose 1MedDRA: Haematochezia — Feeling: GoodFree text: Blood in stool for first few daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
-
2021-04-07
Survey response — day 21, dose 1MedDRA: Localised infection, Peripheral swelling, Pruritus, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Foot infection - swollen and itchy · Healthcare visit (other): Appt tomorrowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-14
Health check-in — day 0, dose 2Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-04-14
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-23
- 2021-05-05
- 2021-05-19
- 2021-05-26
- 2021-07-16
-
2021-12-02
Dose 3 — Moderna
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-04
- 2021-12-05
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-12-16
Survey response — day 14, dose 3MedDRA: Rash, Urticaria — Feeling: FairFree text: Rash and hives on feet, legs, hands, wrists, neckMedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Survey response — day 21, dose 3MedDRA: Skin disorder — Feeling: Good · Be unable to do your normal daily activitiesFree text: More skin issues this time on my toesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — day 28, dose 3MedDRA: Condition aggravated, Pain, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Toe issues have worsened - painful to walk lMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Survey response — day 35, dose 3MedDRA: Rash, Rash pruritic, Rash vesicular, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Feet and rash worsening. Itchy blistering bumps on palms and all over bodyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — day 42, dose 3MedDRA: Fatigue, Headache, Pruritus, Skin disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Skin issues continuing - itch patches on hands feet mainly. Some headaches and tiredness tooMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Survey response — 3 months, dose 3MedDRA: Headache, Skin disorder — Feeling: FairFree text: New or worse than of the Skin conditions. Some headaches.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-25
-
2022-06-04
Survey response — 6 months, dose 3MedDRA: Migraine — Feeling: Poor · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 7, dose 1
Systemic reaction (other): Blood in stool for first few days
Release 7 — day 21, dose 1
Release 10 — day 14, dose 3
Symptoms: Rash and hives on feet, legs, hands, wrists, neck
Release 10 — day 21, dose 3
Symptoms: More skin issues this time on my toes
Release 10 — day 28, dose 3
Symptoms: Toe issues have worsened - painful to walk l
Release 10 — day 35, dose 3
Symptoms: Feet and rash worsening. Itchy blistering bumps on palms and all over body
Release 10 — day 42, dose 3
Symptoms: Skin issues continuing - itch patches on hands feet mainly. Some headaches and tiredness too
Release 11 — 3 months, dose 3
Symptoms: New or worse than of the Skin conditions. Some headaches.
Release 11 — 6 months, dose 3
Symptoms: Migraine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Localised infection | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | Rash vesicular | · | · | ✓ |
| SD | Skin disorder | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Haematochezia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release